Rare diseases
Investigational molecules
Locations
Back to the Netherlands97 clinical trials in Heerlen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on multiple sclerosis and stroke management, including trials evaluating new therapeutic approaches for both relapsing and progressive forms of MS.
Novel therapies being tested include frexalimab and tolebrutinib for multiple sclerosis patients.
Comprehensive studies in cancer treatment, with particular focus on lung cancer, melanoma, and prostate cancer therapies.
Innovative approaches including PSMA-PET/CT imaging and immunotherapy combinations are being evaluated.
Studies addressing cardiovascular diseases and related conditions, including innovative treatments for heart disease and stroke prevention.
Trials include pelacarsen for cardiovascular risk reduction and statin therapy evaluations.
Research into pulmonary conditions, particularly focusing on fibrotic lung diseases and their treatment approaches.
Including trials of inhaled treprostinil and nerandomilast for various forms of lung fibrosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
